Lise Matton

Lise Matton

Auto-generated profile, based on publicly available information

Lise Matton

Service de pneumologie, hôpital Tenon, AP–HP, Paris, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2019 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
JCJacques Cadranel
Jacques Cadranel
ACAnthony Canellas
Anthony Canellas
LMLise Matton
Lise Matton
MDMarie Darrason
Marie Darrason
APAntoine Parrot
Antoine Parrot
VFVincent Fallet
Vincent Fallet
Immune checkpoint inhibitor-related pneumonitis (ICI-P) during cancer treatment is rarely observed (<5%). ICI-P is more often observed in patients with nonsmall cell lung cancer (NSCLC) than in those with other cancers. Likewise, it is more common in those receiving programmed cell death (PD)-1/PD-1 ligand inhibitors rather than cytotoxic T-lymphocyte antigen (CTLA)-4 inhibitors alone. The frequency of ICI-P is higher when anti-PD-1 and anti-CTLA-4 are administered concomitantly. Despite the low fatality rate (≈13%), ICI-P is the leading cause of ICI-related deaths. This narrative review focuses on the epidemiology, clinical and radiological presentation and prognosis of ICI-P occurring in patients, especially those with advanced NSCLC. Emphasis is placed on the differences in terms of frequency or clinical picture observed depending on whether the ICI is used as monotherapy or in combination with another ICI or chemotherapy. Other pulmonary complications observed in cancer patients, yet not necessarily immune-related, are reviewed, such as sarcoid-like granulomatosis, tuberculosis or other infections. A proposal for pragmatic management, including differential diagnosis and therapeutic strategies, is presented, based on the ICI-P series reported in the literature and published guidelines.

1 January 2020 in Revue des Maladies Respiratoires Actualités
Verified
Journal Article
Closed access
LML. Matton
L. Matton
XDX. Dhalluin
X. Dhalluin
ACA. Cortot
A. Cortot
YGYori Gidron
Yori Gidron